TR EN AR RU KK

JANJanOne Inc.

Diğer
🇺🇸 US
Smart Money 26
32.88
USD
Analysis Scores
Lothien Robustness Score?
43/100
Moderate
Neden bu skor?
Damodaran ?
19/100
Dalio Risk ?
81/100
Piotroski ?
N/A
Yetersiz çeyrek verisi: 4 mevcut, en az 5 gerekli
Graham ?
$7.0
Pahalı
Active Metric?
4/4
Confidence?
72%
Lothien Robustness Summary
18/100
Lothien Sağlamlık: Çok Zayıf (18/100)
Temel göstergelerin çoğu olumsuz. Lothien sağlamlık skoru düşük seviyede. | Kısa Vade: Olumlu | Uzun Vade: Nötr | Pozitif: 3 | Negatif: 7 | Nötr: 0
Net Zarar
Son çeyrekte -$4M zarar açıklandı. Yatırımcı dikkatli olmalı.
Çeyreklik Kâr Düşüşü
Net kâr bir önceki çeyreğe göre %-140.3 geriledi ($11M → -$4M). Kısa vadede olumsuz sinyal.
Yıllık Kâr Geriledi
Geçen yılın aynı dönemine göre net kâr %-406.0 düştü. Uzun vadede endişe verici.
3 Çeyrek Üst Üste Düşüş
Son 3 çeyrek üst üste kâr düşüyor. Aşağı trend endişe verici. Sonraki çeyreğe dikkat.
Hasılat Büyümesi Güçlü
Satış gelirleri çeyreklik %+24.0 arttı ($216M → $268M). Talep güçlü.
Yıllık Hasılat Büyümesi Güçlü
Yıllık hasılat %+78.3 arttı. Şirket büyüyor.
Yüksek F/K Uyarısı
Trailing F/K: 100.0. Piyasa yüksek büyüme bekliyor ya da hisse pahalı. Büyüme gerçekleşmezse düşüş riski yüksek.
Yüksek EV/EBITDA
EV/EBITDA: 32.7. Pahalı değerleme.
Düşük ROE
ROE: %1.3. Sermaye getirisi yetersiz — enflasyonun altında.
Sonraki Çeyrek: Artış Beklentisi
Pusla tahminine göre bir sonraki çeyrekte kâr %+150.9 artabilir (-$4M → $2M).

Data date 2026-11-10 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Method How the scores are computed · Scorecard
Data date 2026-11-10
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Risk Analysis (VaR) Orta
162 days
Annual Volatility ?
%29.2
VaR 95% ?
%2.80
daily max loss
VaR 99% ?
%4.05
daily max loss
CVaR 95% ?
%3.02
expected loss (tail)
Max Drawdown ?
%13.8
26.08.2026 → 28.10.2026
Skewness ?
0.46
Parametrik%2.80
Historik%2.69
Cornish-Fisher%2.52
Return Distribution
Valuation
Potential?
-17.9%
ROIC ?
0.1%
DCF Value ?
7.42
Debt Cycle?
Early Expansion
Balance Sheet Analysis? Q2026/9
Net kâr çeyreklik %-140.3 düşerek -4.3M USD oldu
Yıllık net kâr %-406.0 geriledi
Hasılat çeyreklik %+24.0 büyüdü (268.3M USD)
Yıllık hasılat büyümesi güçlü (%+78.3)
Net kâr marjı negatif: %-1.6 — zarar ediyor
Nakit %-78.3 azaldı → 338.1M USD
İşletme nakit akışı pozitif: 111.8M USD
ROE negatif: %-0.1 — zarar var
ROA düşük: %-0.1
Toplam varlıklar %+10.8 büyüdü → 5.2B USD
Özkaynak %+13.7 arttı → 3.1B USD
Fiyat TRAMA-99 üzerinde: %+11.2 — teknik trend olumlu
Destek seviyesi: TRAMA-99 = 29.58 USD
Fundamental & Technical Analysis
Profitability
Net Profit Margin %-1.6
Net profit margin %-1.6 — loss period. Compared to previous quarter -6.6 point decrease.
ROE - Return on Equity (TTM) %1.3
ROE %1.3 — low return on equity.
Free Cash Flow Margin (TTM) %11.7
TTM Free Cash Flow is %11.7'i. Strong FCF generation — profit quality is high.
Valuation
P/E Ratio 100.0x Sector: 26.3x
F/K 100.0x — sector median's (26.3x) %280 above. Expensive zone.
P/B Ratio 2.25x Sector: 4.55x
PD/DD 2.25x — sector median's (4.55x) well below. Cheap relative to book value.
EV/EBITDA 32.7x Sector: 15.6x
EV/EBITDA 32.7x — sector median's (15.6x) %109 above. Expensive relative to EBITDA.
Indebtedness
Current Ratio 1.73x
Current ratio 1.73x — can comfortably cover short-term debts.
Debt / Equity 0.00x
Low leverage — majority of assets financed by equity.
Interest Coverage 82.4x
Interest coverage 82.4x — very wide margin for paying interest expenses.
Growth
Revenue Growth (YoY) %+78.3
Revenue YoY %78.3 grew (2026/9) — strong growth. Sector expansion and/or market share increase.
Net Profit Growth (YoY) %-406.0
Net profit YoY %-406.0 declined (2026/9) — serious profit erosion.
Score Explanations
Lothien Robustness
43/100
Moderate robustness (43/100). Valuation and risk criteria give mixed signals. Detailed review recommended.
Moderate
Potential
-17.9%
Minus %17.9 expected value (26.59) vs current price comparison. 4/4 valuation models could be calculated. Model confidence %72.
Components: PE target: 8.10 | P/B target: 65.66 | EV/EBITDA target: 15.49 | DCF target: 8.10
Damodaran Valuation
19/100
Low Damodaran score (19/100). ROIC (%0.1) below cost of capital. DCF analysis does not support current price.
Very Weak
Dalio Risk Analysis
81/100
Low debt risk (81/100). Interest coverage ratio 82.4x — strong.
Leverage: 100/100 | Debt Service: 100/100 | Quality: 33/100
ROIC - Return on Capital
%0.1
ROIC (%0.1) cost of capital (11.3%) below → destroying value.
WACC: %11.3
DCF Discounted Cash Flow
7.42
DCF (7.42) current price %77.1 below — cash flows do not support current price.
Current price: 32.39
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
—
Graham Intrinsic Value
$7.0
Expensive
⚖️ Sector Comparison
P/E Ratio
100.0x vs 26.3x
Sector median's %280 above — expensive
P/B Ratio
2.25x vs 4.55x
Compared to sector %51 cheaper (by book value)
EV/EBITDA
32.7x vs 15.6x
Compared to sector %109 higher EV/EBITDA
ROIC vs WACC
%0.1 vs %11.3 WACC
ROIC 11.2 bps below cost of capital
Net Profit Margin (TTM)
%4.7 vs %25.6 EBITDA margin
TTM net profit margin %4.7
TRAMA-99 Trend — Uptrend
Price (32.88), TRAMA-99 line's %11.2 above. Uptrend ongoing; monitor for TRAMA approach for trend change.
Price:: 32.88
TRAMA: 29.58
Difference: %+11.2
Charts
Indicators
BB deviation ?
RSI thresholds ?

Price Chart ?
▲ içeriden alım · ▼ içeriden satım · ★ katalizör (haber-sezgisel) · ■ 13D aktivist · ■ 13G pasif — SEC Form 4 ~2 gün gecikmeli, yalnız yönetici/direktör/%10+ sahip; katalizör = haber-sezgisel; 13D/G = %5+ pay bildirimi ~5 iş günü gecikmeli.
RSI (14) ?
Bollinger Bands ?
MACD ?
Gold-Based Price + TRAMA (Stock / Gram Gold) ?
Kurumsal Holdings — 13F (çeyreklik) ?

İçeriden Alım-Satım Akışı

Kim aldı, kim sattı, ne kadar

JAN — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.